CLVLY   $12.91  -2.20% Market Closed

CLINUVEL PHARMS LTD S/ADR
Total Cash 183.87M
totalCashPerShare 3.672
EBITDA 49.32M
Total Debt 879.78K
quickRatio 8.334
currentRatio 8.808
Total Revenue 88.18M
debtToEquity 0.433
Revenue/Share 1.769
ROA 0.1429
ROE 0.19386
grossProfits
freeCashflow 23.45M
operatingCashflow 37.05M
earningsGrowth 0.32
revenueGrowth 0.131
grossMargins 0.91230005
ebitdaMargins 0.55934
operatingMargins 0.6261
profitMargins 0.40414003
enterpriseValue 266.46M
forwardPE
floatShares 41.52M
sharesOutstanding 50.06M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.0
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 4.054
Price To Book help_outline 2.22
earningsQuarterlyGrowth 0.29
netIncomeToCommon 35.64M
trailingEps 0.46%
forwardEps
enterpriseToEbitda 5.40
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Nov. 6, 2024, 7:46 p.m.